Boston Scientific (BSX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1011371077

Medical Devices, Stents, Catheters, Implants, Electrophysiology Systems

Boston Scientific Corporation is a leading medical device company that develops, manufactures, and markets innovative solutions to improve healthcare worldwide. With a strong presence in over 100 countries, the company operates through two main segments: MedSurg and Cardiovascular.

In the MedSurg segment, Boston Scientific offers a wide range of devices to diagnose and treat various gastrointestinal and pulmonary conditions. These include resolution clips, biliary stent systems, stents, and electrocautery enhanced delivery systems, as well as direct visualization systems, digital catheters, and single-use duodenoscopes. The company also provides devices to treat urological conditions, such as ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, and holmium laser systems.

In addition, Boston Scientific offers devices to treat neurological movement disorders and manage chronic pain. These include spinal cord stimulator systems, proprietary programming software, radiofrequency generators, indirect decompression systems, practice optimization tools, and deep brain stimulation systems.

In the Cardiovascular segment, the company provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions. This includes the WATCHMAN FLX, a Left Atrial Appendage Closure Device, as well as implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. These devices include cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems.

Boston Scientific also offers diagnosis and treatment solutions for rate and rhythm disorders of the heart, peripheral arterial and venous diseases, and products to diagnose, treat, and ease forms of cancer. With a strong commitment to innovation and improving patient outcomes, the company has been a leader in the medical device industry since its incorporation in 1979. Headquartered in Marlborough, Massachusetts, Boston Scientific continues to drive advancements in medical technology and care.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Boston Scientific (BSX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Boston Scientific (BSX) - Stock Price & Dividends

BSX Stock Overview

Market Cap in USD 113,204m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1992-05-18

BSX Stock Ratings

Growth 5y 64.9
Fundamental 49.3
Dividend -
Rel. Performance vs Sector 2.35
Analysts 4.53/5
Fair Price Momentum 78.89 USD
Fair Price DCF 28.95 USD

BSX Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

BSX Growth Ratios

Growth 12m 43.99%
Growth Correlation 12m 77%
Growth Correlation 3m 79%
CAGR 5y 13.06%
CAGR/Mean DD 5y 1.53
Sharpe Ratio 12m 2.03
Alpha vs SP500 12m 15.62
Beta vs SP500 5y weekly 1.04
ValueRay RSI 66.67
Volatility GJR Garch 1y 19.32%
Price / SMA 50 5.58%
Price / SMA 200 24.62%
Current Volume 9938.2k
Average Volume 20d 5423.8k

External Links for BSX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BSX stocks?
As of June 22, 2024, the stock is trading at USD 77.71 with a total of 9,938,194 shares traded.
Over the past week, the price has changed by +1.24%, over one month by +2.70%, over three months by +15.02% and over the past year by +44.01%.
What are the forecast for BSX stock price target?
According to ValueRays Forecast Model, BSX Boston Scientific will be worth about 87.5 in June 2025. The stock is currently trading at 77.71. This means that the stock has a potential upside of +12.64%.
Issuer Forecast Upside
Wallstreet Target Price 82.8 6.59
Analysts Target Price 61.2 -21.3
ValueRay Target Price 87.5 12.6

Boston Scientific Corp: Pioneering Medical Solutions

History and Transformation

Boston Scientific Corporation, founded in 1979, has been at the forefront of the medical devices industry. The journey began with its founders, John Abele and Pete Nicholas, who aimed to provide less invasive, more accessible medical solutions. Boston Scientific distinguished itself early on by introducing groundbreaking medical devices, leading the charge towards less invasive medical treatments globally.

Core Business Focus

At its heart, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The company excels in various medical areas, including interventional cardiology, rhythm management, endoscopy, neuromodulation, urology and pelvic health, and peripheral interventions. Boston Scientific's commitment to enhancing patient outcomes through less invasive procedures drives its continuous growth and innovation in these areas.

Expanding Horizons: Side Businesses

Beyond its core products, Boston Scientific has diversified into related healthcare services and solutions, broadening its impact. This includes the development of digital health solutions and services designed to improve patient care, drive efficiencies in healthcare delivery, and offer value beyond their core device offerings. Their involvement in healthcare education for professionals, alongside investments in research and development, signifies a broad-based approach to changing the face of medicine.

Current Market Status

As of the latest market analyses, Boston Scientific Corporation (NYSE:BSX) remains a formidable player in the medical devices sector. The company has shown resilience and adaptability, continuously posting strong financial performance despite challenges posed by global economic changes and the healthcare landscape. Its commitment to innovation, coupled with a strategic approach to market challenges and opportunities, positions Boston Scientific well for future growth.